Wednesday January 13, 2021
Chief Medical Officer Paul Kelly has defended Australia’s coronavirus vaccine rollout, despite concerns about one of the drugs at the centre of the strategy.
Chief Medical Officer Professor Paul Kelly moved to ease concerns over vaccine effectiveness. (AAP Image/Lukas Coch)
Kelly sought to ease concerns about the effectiveness of a leading coronavirus vaccine after some some doctors said that the vaccine developed by Oxford University and AstraZeneca may not be enough to achieve herd immunity.
The drug has an efficacy rate of between 62 and 90 per…